141 related articles for article (PubMed ID: 2544843)
1. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants.
Redding SW; Montgomery MT
Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):680-3. PubMed ID: 2544843
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation.
Epstein JB; Ransier A; Sherlock CH; Spinelli JJ; Reece D
Eur J Cancer B Oral Oncol; 1996 May; 32B(3):158-62. PubMed ID: 8762872
[TBL] [Abstract][Full Text] [Related]
3. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus and oral mucositis in children with cancer.
Carrega G; Castagnola E; Canessa A; Argenta P; Haupt R; Dini G; Garaventa A
Support Care Cancer; 1994 Jul; 2(4):266-9. PubMed ID: 8087447
[TBL] [Abstract][Full Text] [Related]
5. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
Wade JC; Day LM; Crowley JJ; Meyers JD
J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
[TBL] [Abstract][Full Text] [Related]
6. The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients.
Woo SB; Sonis ST; Sonis AL
Cancer; 1990 Dec; 66(11):2375-9. PubMed ID: 2173971
[TBL] [Abstract][Full Text] [Related]
7. [Use of acyclovir in the prevention of herpes infections after allogenic bone marrow grafts].
Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Pérol Y
Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):391-6. PubMed ID: 6091231
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of herpes simplex virus infection in leukemia.
Epstein JB; Sherlock C; Page JL; Spinelli J; Phillips G
Oral Surg Oral Med Oral Pathol; 1990 Jul; 70(1):38-43. PubMed ID: 2164654
[TBL] [Abstract][Full Text] [Related]
10. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y
Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394
[TBL] [Abstract][Full Text] [Related]
11. Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis.
Redding SW
NCI Monogr; 1990; (9):103-5. PubMed ID: 2160612
[TBL] [Abstract][Full Text] [Related]
12. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection.
Schubert MM; Peterson DE; Flournoy N; Meyers JD; Truelove EL
Oral Surg Oral Med Oral Pathol; 1990 Sep; 70(3):286-93. PubMed ID: 2170891
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
14. Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit.
Rayani SA; Nimmo CJ; Frighetto L; Martinusen SM; Nickoloff DM; Reece DE; Jewesson PJ
Ann Pharmacother; 1994; 28(7-8):852-6. PubMed ID: 7949499
[TBL] [Abstract][Full Text] [Related]
15. Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.
Shepp DH; Dandliker PS; Flournoy N; Meyers JD
J Antimicrob Chemother; 1985 Sep; 16(3):389-95. PubMed ID: 2997101
[TBL] [Abstract][Full Text] [Related]
16. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.
Seale L; Jones CJ; Kathpalia S; Jackson GG; Mozes M; Maddux MS; Packham D
JAMA; 1985 Dec; 254(24):3435-8. PubMed ID: 2999455
[TBL] [Abstract][Full Text] [Related]
17. The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy.
Montgomery MT; Redding SW; LeMaistre CF
Oral Surg Oral Med Oral Pathol; 1986 Mar; 61(3):238-42. PubMed ID: 3010211
[TBL] [Abstract][Full Text] [Related]
18. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
Wade JC; Newton B; Flournoy N; Meyers JD
Ann Intern Med; 1984 Jun; 100(6):823-8. PubMed ID: 6326632
[TBL] [Abstract][Full Text] [Related]
19. The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections.
Bernstein DI; Lovett MA; Bryson YJ
J Infect Dis; 1984 Jul; 150(1):7-13. PubMed ID: 6086772
[TBL] [Abstract][Full Text] [Related]
20. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
